Usetutoringspotscode to get 8% OFF on your first order!

  • time icon24/7 online - support@tutoringspots.com
  • phone icon1-316-444-1378 or 44-141-628-6690
  • login iconLogin

Business Ethics

 

Stanford University medical researchers conducted a study on the correlation between the use of fertility drugs and ovarian cancer.  Their study, published in the American Journal of Epidemiology, concludes that the use of the fertility drugs, Pergonal and Serophene, may increase the risk of ovarian cancer by three times.  The lead author of the studies, Professor Alice Whittemore, stated, “Our finding in regard to fertility drugs is by no means certain.  It is based on very small numbers and is really very tenuous.”

FDA Commissioner David Kessler would like the infertility drug manufacturers to disclose the study findings and offer a warning on the drug packages.  He notes, “Even though the epidemiology study is still preliminary, women have a right to know what is known.  We’re not looking to make more of this than there is.”

If you were a manufacturer of one of the drugs, would you voluntarily disclose the study information? Why or why not?

Use at least two (2) academically reviewed journal articles as research for your response fully discuss this question.

 This posting should be at least 250 words.  Your post can end with a “tag-line” or a related question of your own.

You can leave a response, or trackback from your own site.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes